Plans submitted for Whitechapel life sciences and housing campus
Mixed-use scheme to deliver research space, key worker housing and green public realm.
4 February 2026
Plans have been submitted for a major redevelopment project in Whitechapel that would see land next to The Royal London Hospital transformed into a hub for life sciences research, housing and community amenities.
The proposal, led by global real estate firm BGO in partnership with Barts Health NHS Trust, forms part of the emerging Barts Life Sciences Cluster and would deliver almost one million square feet of new development. The long-term scheme includes purpose-built research facilities, office space for life sciences companies, over 500 new homes, and green public spaces.
If approved by Tower Hamlets Council, the development is expected to generate £750 million of investment over the next decade and contribute £1 billion a year to the UK economy. More than 1,300 jobs are projected to be created through the scheme.
A central element of the proposal is the redevelopment of land to the south of the hospital, replacing existing NHS administrative buildings including Ashfield Street offices, John Harrison House and Princess Alexandra House. The new building would include flexible workspace for research and innovation firms, staff amenities and landscaped public areas.
The housing component will deliver a mix of private apartments, affordable homes and key worker accommodation. Refurbished terraced homes are included, and streets such as Philpot Street and Walden Street are to be redesigned as green pedestrian routes.
Shane DeGaris, group chief executive of Barts Health NHS Trust, described the proposal as a major opportunity to support staff, patients and the wider community. “This is an exciting example of how we are working with local partners to bring much-needed investment into Whitechapel and regenerate the area around our flagship teaching hospital,” he said.
The scheme forms part of the broader Barts Life Sciences initiative, which aims to accelerate the translation of medical research into clinical applications. The Trust will continue working with BGO and other partners to attract industry and expand the cluster.
Subject to planning approval, demolition work could begin in 2027, with phased construction expected to continue over a 10-year period. The Trust has committed to engaging with affected staff in advance of any relocation plans.
